Treatment Of Neurological Diseases


Methods treat neurological disorders, for example neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and stroke. Particularly although not exclusively, GIP/GLP-1 co-agonist peptide is used in the treatment of such neurological disorders. Pharmaceutical compositions include a GIP/GLP-1 co-agonist peptide for use in treatment of such disorders.

Download PDF
Document Preview
Document History
  • Publication: Feb 6, 2018
  • Application: Jul 14, 2015
    US US 201514799143 A
  • Priority: Jul 15, 2014
    GB GB 201412578 A

Download Citation

Sign in to the Lens